Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tin Khor"'
Autor:
Fei Wu, Pei-Ming Chen, Thomas C. Gardinier, Melik Z. Turker, Aranapakam M. Venkatesan, Vaibhav Patel, Tin Khor, Michelle S. Bradbury, Ulrich B. Wiesner, Gregory P. Adams, Geno Germano, Feng Chen, Kai Ma
Publikováno v:
ACS nano. 16(12)
To address the key challenges in the development of next-generation drug delivery systems (DDS) with desired physicochemical properties to overcome limitations regarding safety, in vivo efficacy, and solid tumor penetration, an ultrasmall folate rece
Autor:
Gregory P. Adams, Tin Khor, Feng Chen, Kai Ma, Marion Scocca, Aranapakam Venkatesan, Cathy Reddick, Mary Hilgart, Thomas Gardinier, Fei Wu, Melik Turker, Peiming Chen, Vaibhav Patel, Eliel Bayever
Publikováno v:
Cancer Research. 83:837-837
Antibody-drug conjugates (ADCs) exhibit limited efficacy against brain malignancies due to their inability to cross the blood-brain barrier (BBB) and penetrate into solid tumors. In clinical imaging studies C’Dots readily crossed tumor-disrupted BB
Autor:
Gregory P. Adams, Kai Ma, Feng Chen, Marion Scocca, Aranapakam Venkatesan, Cathy Reddick, Mary Hilgart, Thomas Gardinier, Fei Wu, Melik Turker, Peiming Chen, Tin Khor, Vaibhav Patel, Eliel Bayever
Publikováno v:
Cancer Research. 82:1077-1077
While several antibody-drug conjugates (ADCs) have shown efficacy in the treatment of solid tumors ADCs remain limited in their therapeutic efficacy due to long circulatory half-life and limited tumor penetration. Ultra-small (sub-10nm) C’Dot-drug-
Autor:
Quy Le, Feng Chen, Thao Tang, Cynthia Nourigat McKay, Fei Wu, Melik Turker, Thomas Gardinier, Vaibhav Patel, Aranapakam Venkatesan, Tin Khor, Kai Ma, Gregory P. Adams, Soheil Meshinchi
Publikováno v:
Cancer Research. 82:1075-1075
Acute myeloid leukemia (AML) in infants is a unique subtype of AML that is driven by oncogenic fusions, resulting in a highly proliferative disease. The CBFA2T3-GLIS2 oncogenic fusion that is seen exclusively in infants and young children Citation Fo
Autor:
Yonathan Lissanu Deribe, Yuting Sun, Christopher Terranova, Fatima Khan, Juan Martinez-Ledesma, Jason Gay, Guang Gao, Robert A. Mullinax, Tin Khor, Ningping Feng, Yu-Hsi Lin, Chia-Chin Wu, Claudia Reyes, Qian Peng, Frederick Robinson, Akira Inoue, Veena Kochat, Chang-Gong Liu, John M. Asara, Cesar Moran, Florian Muller, Jing Wang, Bingliang Fang, Vali Papadimitrakopoulou, Ignacio I. Wistuba, Kunal Rai, Joseph Marszalek, P. Andrew Futreal
Lung cancer is a devastating disease that remains a top cause of cancer mortality. Despite improvements with targeted and immunotherapies, the majority of patients with lung cancer lack effective therapies, underscoring the need for additional treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a2e4358fcfc6e14269b6462014d8e9
https://europepmc.org/articles/PMC6650267/
https://europepmc.org/articles/PMC6650267/
Autor:
Yonathan Lissanu Deribe, Yuting Sun, Christopher Terranova, Fatima Khan, Juan Martinez-Ledesma, Jason Gay, Guang Gao, Robert A. Mullinax, Tin Khor, Ningping Feng, Yu-Hsi Lin, Chia-Chin Wu, Claudia Reyes, Qian Peng, Frederick Robinson, Akira Inoue, Veena Kochat, Chang-Gong Liu, John M. Asara, Cesar Moran, Florian Muller, Jing Wang, Bingliang Fang, Vali Papadimitrakopoulou, Ignacio I. Wistuba, Kunal Rai, Joseph Marszalek, P. Andrew Futreal
Publikováno v:
Nature Medicine. 24:1627-1627
In the version of this article originally published, information regarding several funding sources was omitted from the Acknowledgements section. The following sentences should have been included: "This work was supported by the generous philanthropi
Publikováno v:
Pharmaceutical Research; Jan2009, Vol. 26 Issue 1, p224-231, 8p
Publikováno v:
Pharmaceutical Research; Sep2008, Vol. 25 Issue 9, p2181-2189, 9p
Publikováno v:
Pharmaceutical Research; Apr2008, Vol. 25 Issue 4, p836-844, 9p
Autor:
Sujit Nair, Vidya Hebbar, Guoxiang Shen, Avantika Gopalakrishnan, Tin Khor, Siwang Yu, Changjiang Xu, Ah-Ng Kong
Publikováno v:
Pharmaceutical Research; Feb2008, Vol. 25 Issue 2, p387-399, 13p